EP1718278A1 - Mikrokapsel mit steuerbarer oder verzögerter freisetzung zur immobilisierung von chemischen und/oder biologischen materialien sowie verfahren zu ihrer herstellung - Google Patents
Mikrokapsel mit steuerbarer oder verzögerter freisetzung zur immobilisierung von chemischen und/oder biologischen materialien sowie verfahren zu ihrer herstellungInfo
- Publication number
- EP1718278A1 EP1718278A1 EP05701273A EP05701273A EP1718278A1 EP 1718278 A1 EP1718278 A1 EP 1718278A1 EP 05701273 A EP05701273 A EP 05701273A EP 05701273 A EP05701273 A EP 05701273A EP 1718278 A1 EP1718278 A1 EP 1718278A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- capsule
- substance
- microcapsule according
- beads
- core
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Definitions
- Controllable or delayed release microcapsule for immobilizing chemical and / or biological materials and process for their manufacture
- the invention relates to a microcapsule, in particular for the immobilization of chemical and / or biological material, and a method for its production, which is stable in concentrated media, but which is destroyed when the medium is diluted, even with a relatively low mechanical load, as a result of which trapped material is released.
- this material can be both a chemical substance such as. B. an active ingredient or an enzyme, etc., or biological material such as microorganisms, cells or mixtures thereof.
- Such a capsule consists of a preferably spherical core that immobilizes the
- the invention relates to a microcapsule, in particular for the immobilization of chemical and / or biological material, and a method for its production, which is destroyed with a time delay by an enzymatic and / or other chemical or physical process with relatively low mechanical stress, as a result of which the enclosed one Material is released.
- this material can be both a chemical substance such as. B. an active ingredient, etc. or biological material such as microorganisms, cells or mixtures thereof.
- the inside of the capsule contains, for example, an enzyme that is inactive when the capsule is stored, but can be activated by external factors. As a result of this activation, the enzyme cleaves one or more components that make up the capsule.
- the originally stable capsule becomes mechanically unstable and the enclosed material can be released even with relatively little mechanical stress.
- the components are usually incorporated individually and in a dry form and the mixture is stored in a dry form.
- encapsulation is very common in the specialist literature. On an industrial scale, processes have mainly prevailed in which carrier particles are first produced, which are subsequently loaded with an active ingredient. So-called immersion processes, such as those used, for example, in the manufacture of medicines or sweets, are often referred to as encapsulation, or spray coatings as are widespread in the chemical or pharmaceutical industry. Solids are coated with a membrane by dipping or spraying. For special applications, substances are often enclosed in gel particles by chemical precipitation.
- microcapsules There are also numerous industrial property rights or industrial property right applications relating to microcapsules.
- the published patent application DE 196 44 343 AI describes a microcapsule with a diameter of a few ⁇ m, which is produced in an emulsion process.
- oils or substances soluble in this oil become one basic material
- emulsified alginate and formed it into capsules 0.5 - 20 ⁇ m in size in a further emulsion process, which can then be used in the food or pharmaceutical industry.
- these beads are not suitable for the immobilization of larger solid particles, or even living cells. Nor can they be used for the purpose according to the invention.
- So-called membrane capsules are in a class of their own.
- F. Lim and A. Sun in the journal “Science Volume 210, pages 908-910, year 1980, describe a capsule with a semipermeable membrane for immobilizing living cells in which the capsule core consists of a single layer of a ply-I-lysine / alginate complex is surrounded. With these capsules, the cells are prevented from escaping from the capsule core.
- molecules the size of an enzyme or smaller cannot be included since the membrane is permeable to it.
- This membrane capsule is also not suitable for use in technical processes because of its relatively low mechanical stability.
- Patent application DE 43 12 970.6 describes a membrane capsule which is also suitable for immobilizing enzymes and proteins.
- the core which contains the immobilizate, surrounded by a multilayer shell, each of these layers imparting a certain property to the entire shell.
- the permeability of the membrane can be reduced so that the enzymes remain in the capsule, while the much smaller substrates and products can pass through the membrane.
- These capsules are stable at very different concentrations of the surrounding medium.
- the membranes have a fixed, defined permeability and thus prevent release of the enclosed material.
- the patent specification EP 0 782 853 B1 describes a microcapsule whose shell is made up of several special layers. At least one of these layers consists of a material that changes its structure and thus the pore size of the shell as a function of an internal concentration and / or other physical quantities. With this capsule, the core is always preserved. Only the shell changes its permeability, which allows a partial but not a complete release of the enclosed material.
- Carrageenan, polyvinyl alcohol or cellulose ether include known.
- the polymers and the electrolytes are selected so that the stability of the capsules on average and their dissolution upon dilution are ensured.
- the polymers used are not suitable for the encapsulation of living material.
- British Patent 1,471,406 relates to liquid, aqueous detergents with capsules with a diameter of 0.1 to 5 mm. These capsules are intended to make sensitive ingredients more stable in temperature, storage and transp. Location and only immediately before or during use freely translated. The ingredients are either wholly or partially enclosed by the capsules, the capsules not being further defined.
- fruit juice concentrates which, when stored in gel form, contain active ingredients which should only be activated when diluted, i.e. when water is added.
- the object of the invention is to produce a capsule which can contain both inanimate substances and living organisms. At the same time, its mechanical strength can be adjusted so that it can be used in technical processes. It is stable in concentrated media and is destroyed when the medium is changed or diluted with a relatively low mechanical load, thus releasing the enclosed material.
- the capsule should be usable in a variety of media, not impair bleeding and at the same time be able to be dried without loss of function.
- the object is achieved according to a first aspect in that, in a first step, a capsule in liquid phase is produced which completely encloses the material to be encapsulated. In a second step, the capsule is dried. It is then stored in the concentrate (e.g. gel) for several hours. When the capsule concentrate suspension is diluted, such high voltages build up in the capsule that a slight mechanical stress leads to its destruction and release of the encapsulated material.
- the concentrate e.g. gel
- the core idea of the invention according to the first aspect is therefore to first dry the matrix from which the capsule is made and then to soak it with a concentrated medium, so that when the surrounding medium is diluted, the capsule is destroyed by the stress occurring inside. The material that is enclosed in the capsule matrix is released. In order to prevent bleeding of the material in the capsule during storage, the capsule can be surrounded by an envelope membrane.
- a number of different materials can be enclosed in such a capsule, such as, for example: water-soluble or water-insoluble substances - Fats, oils, emulsions or suspensions - Solids - Living or dead cells - Living or dead microorganisms - Mixtures from one or more of the above classes
- the capsule core consists of a basic substance from which a matrix is formed, in which the material to be immobilized is embedded.
- This basic substance must be a substance that can be dripped, from which preferably spherical porous particles can be formed by means of precipitation by the action of ions or a temperature gradient.
- Such substances can e.g. B. Na alginate but also agarose or Sephadex etc.
- This membrane can consist of a polyelectrolyte complex that can be applied in several layers.
- polyelectrolyte complexes are formed from the interaction of a polyanion and polycations.
- a polyanion for example, water-soluble cellulose derivatives such. B. carboxy methyl cellulose, cellulose sulfate or Pecti ⁇ e, alginates but also synthetic polymers such as polyacrylic or polymethacrylic acids, etc. to use.
- the polycation that can be used is primarily natural substances such as chitosan but also synthetic polymers such as polyethyleneimine or polydiethyldiallylammonium chloride.
- the above-mentioned membrane can also be produced by direct coating with various substances.
- This coating can either take place during a possible drying of the capsules or can be applied by subsequent coating. If the capsules are to be used in the food or pharmaceutical sector, this coating Substance either, for example, shellac or another substance approved for the respective area.
- this coating Substance either, for example, shellac or another substance approved for the respective area.
- other film-forming compounds such as. B. nitrocellulose derivatives or polyvinyl acetates, etc. can be used.
- a capsule with a combination of the two above.
- a method for producing a microcapsule according to the first aspect is as follows:
- the material to be encapsulated is stirred into a 1-2% base solution, for example Na alginate.
- a filler such as quartz sand or silica is then mixed in, so that the mixture then has a dry content of e.g. B. has about 20-40%.
- This mixture is then dripped into a precipitation bath. This dripping can be done by any commercially available system that provides uniform droplet sizes. The best results were achieved with so-called two-component nozzles. These are nozzles in which the drops on the capillaries through which the mixture is pressed are carried out by a concentrated air flow.
- the precipitation bath can be a 1-2% saline solution containing one or more polyvalent metal ions, such as. B. Ca ++ , Ba ++ , etc. If a dilute solution of a polycation is added to the precipitation bath, such as polyethyleneimine, chistosan, etc., a thin membrane is formed at the same time as the precipitation, which prevents the enclosed material from bleeding out of the capsule. By repeatedly rinsing this capsule with differently charged polyelectrolyte solutions, a membrane can be built up which gives the capsule a mechanical strength that corresponds to the application. In this process, it is advantageous that this Rinsing takes place in the form of a fluidized bed. For this purpose, the capsules are washed in a suitable vessel by the coating solutions at a speed which is large enough not only to swirl the beads, but also to keep them in suspension.
- the beads are then washed and dried. Drying can be done with commercially available dryers, with the best results being achieved with fluidized bed or vibration batch dryers.
- the moisture level after drying should not be higher than 3% - 7%.
- the object is achieved in that, in a first step, a capsule is produced in the liquid phase, which completely encloses the material to be encapsulated. In a second step, the capsule is dried.
- the matrix substance of the capsule or the shell contains at least one substance that can be changed either enzymatically or by other physical and / or chemical processes, so that the mechanical stability of the entire capsule is no longer ensured.
- This change can be caused, for example, by an enzyme which contains the capsule and which is inactive in the dry capsule or under the conditions in which the capsule is stored.
- the enzyme becomes active when the capsule is moistened or through a change in the physico-chemical parameters of the surrounding medium.
- the enzyme cleaves one or more components of the capsule. This becomes mechanically unstable and releases the enclosed material.
- this effect cannot only be generated enzymatically. If the capsule is hardened in a reversible process, which can be reversed by adding certain ragents, the capsule can be dissolved again at a later time, thereby releasing the enclosed material.
- the core idea of the invention according to the second aspect is therefore to choose the matrix and / or a possible shell from which the capsule is made so that it can be destroyed by changing external physical and / or chemical parameters. This can e.g. by activating an enzyme in the interior of the capsule that cleaves essential components of the capsule material. This destruction of the capsule can also be done in another way. The material that is enclosed in the capsule matrix is released. In order to prevent bleeding of the material in the capsule during storage, the capsule can be surrounded by an envelope membrane.
- a number of different materials can be enclosed in such a capsule, such as: - water-soluble or water-insoluble substances - fats, oils, emulsions or suspensions - solids - living or dead cells - living or dead microorganisms - Mixtures of one or more of the above classes
- the capsule core consists of a basic substance from which a matrix is formed, in which the material to be immobilized is embedded.
- This basic substance must be a substance that can be dripped, from which it is preferred to precipitate by ionic action or a temperature gradient spherical porous particles can be formed.
- Such substances can e.g. B. Na alginate but also agarose or Sephadex etc.
- This membrane can consist of a polyelectrolyte complex that can be applied in several layers.
- polyelectrolyte complexes are formed from the interaction of a polyanion and polycations.
- a polyanion for example, water-soluble cellulose derivatives such. B. carboxy methyl cellulose, cellulose sulfate or pectins, alginates but also synthetic polymers such as polyacrylic or polymethacrylic acids, etc. to use.
- the polycation that can be used is primarily natural substances such as chitosan, but also synthetic polymers such as polyethyleneimine or polydiethyldiallylammonium chloride.
- the membrane can also be produced by direct coating with various substances. This coating can either take place during a possible drying of the capsules or can be applied by subsequent coating. If the capsules are to be used in the food or pharmaceutical sector, this coating substance can either be shellac, for example, or another substance approved for the respective region.
- this coating substance can either be shellac, for example, or another substance approved for the respective region.
- other film-forming compounds such as. B. nitrocellulose derivatives or polyvinyl acetates, etc. can be used.
- Capsule would have an additional parameter to influence the storage properties and to prevent bleeding of the enclosed material and / or an interaction with the surrounding medium during storage, which increases its reliability.
- a method for producing a microcapsule according to the invention in accordance with the second aspect is as follows:
- Example 1 Capsule with enzymatic release
- the material to be encapsulated is stirred into a 1-2% base solution, for example Na alginate.
- This base solution can also contain pectin in a similar concentration as the alginate.
- a filler such as quartz sand or silica can then be added, so that the mixture then has a dry content of e.g. B. has about 20-40%.
- pectinase is added to the mixture in a concentration of n 0,000 U / kg of mixture.
- This mixture is then buffered to a pH of approximately 4 and added dropwise to a precipitation bath. This dripping can be done by any commercially available system that provides uniform droplet sizes. The best results were achieved with so-called two-component nozzles. These are nozzles, in which the tear on the capillaries through which the mixture is pressed is carried out by a concentric air flow.
- the precipitation bath can be a 1-2% saline solution containing one or more polyvalent metal ions, such as. B. Ca ++ , Ba ++ , etc.
- a dilute solution of a polycation is added to the precipitation bath, such as polyethyleneimine, chistosan, etc.
- a thin membrane is formed at the same time as the precipitation, which prevents the enclosed material from bleeding out of the capsule.
- diluted solutions of chitosan, polyethyleneimine, etc. can be used as the polycation.
- Dilute solutions of pectins, alginate etc. can be used as the polyanion.
- this rinsing takes place in the form of a fluidized bed.
- the capsules are washed with the coating solutions in a suitable vessel at a rate big enough not only to swirl the beads but also to keep them in suspension.
- the beads are then washed and dried. Drying can be done with commercially available dryers, with the best results being achieved with fluidized bed or vibration batch dryers. The moisture level after drying should not be higher than 3-7%.
- the capsule After drying, the capsule is dry and stored at a low temperature. If the capsule is moistened at a later point in time, the enzyme is activated and it cleaves the polyguluron chains of the pectin components and other corresponding components of the capsule (e.g. alginate) both in the core and in the shell. This destabilizes the capsule to such an extent that small mechanical loads are sufficient to destroy the capsule and release the enclosed material.
- the enzyme is activated and it cleaves the polyguluron chains of the pectin components and other corresponding components of the capsule (e.g. alginate) both in the core and in the shell. This destabilizes the capsule to such an extent that small mechanical loads are sufficient to destroy the capsule and release the enclosed material.
- Example 1 the material to be encapsulated is stirred into a 1-2% base solution, for example Na alginate, in a first step.
- a filler such as quartz sand or silica can be added, so that the mixture then has a dry content of e.g. B. has about 20-40%. However, this filler is also missing.
- This mixture is then dripped into a precipitation bath. This dripping can be done by any commercially available system that provides uniform droplet sizes. The best results were achieved with so-called two-component nozzles.
- nozzles in which the tear on the capillaries through which the mixture is pressed is carried out by a concentric air flow. If necessary, the particles obtained can be coated as described in Example 1. Although the beads are ready to use when wet, it is beneficial to dry them.
- Drying can be done with commercially available dryers, with the best results being achieved with fluidized bed or vibration batch dryers.
- the moisture level after drying should not be higher than 3-7%.
- a medium that destroys the capsules thus obtained is, for example, a 1-2% aqueous solution of Na citrate.
- an alkali with a strongly alkaline pH can be used.
- the capsules are brought into contact with such a medium, the reversible gelling process in the precipitation bath is reversed and the capsule dissolves.
- the dry capsules are added to a dry baking mixture that also contains Na citrate and this mixture is moistened, the beads are destroyed and the trapped material is released.
- the capsule can also be destroyed by removing complexing agents from the ions in the medium surrounding the capsule matrix, thereby destabilizing them.
- complexing agents are often present in detergents. If these extract Ca ++ from a capsule matrix consisting, for example, of Ca alginate, it will retain its spherical shape in gel, but due to its low stability when the surrounding gel is diluted, it will be completely destroyed even with slight mechanical stress. This releases the material trapped in the capsule. If such a capsule has an envelope membrane, the stability in the gel can be regulated when the complexing agents act. With such a mechanism of action, the capsule can be used both in the moist and in the dried state.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200410005054 DE102004005054A1 (de) | 2004-01-31 | 2004-01-31 | Mikrokapsel mit steuerbarer Freisetzung zur Immobilisierung von chemischen und/oder biologischen Materialien sowie Verfahren zu ihrer Herstellung |
DE200410009051 DE102004009051A1 (de) | 2004-02-23 | 2004-02-23 | Mikrokapsel mit verzögerter Freisetzung zur Immobilisierung von chemischen und/oder biologischen Materialien sowie Verfahren zu ihrer Herstellung |
PCT/EP2005/000927 WO2005072708A1 (de) | 2004-01-31 | 2005-01-31 | Mikrokapsel mit steuerbarer oder verzögerter freisetzung zur immobilisierung von chemischen und/oder biologischen materialien sowie verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1718278A1 true EP1718278A1 (de) | 2006-11-08 |
Family
ID=34828329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05701273A Withdrawn EP1718278A1 (de) | 2004-01-31 | 2005-01-31 | Mikrokapsel mit steuerbarer oder verzögerter freisetzung zur immobilisierung von chemischen und/oder biologischen materialien sowie verfahren zu ihrer herstellung |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070292687A1 (ja) |
EP (1) | EP1718278A1 (ja) |
JP (1) | JP2007534466A (ja) |
CA (1) | CA2553657A1 (ja) |
WO (1) | WO2005072708A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006049039A1 (de) * | 2006-10-13 | 2008-04-17 | Cavis Microcaps Gmbh | Mikrokapsel zum Einbringen von Stoffen in Kosmetika |
KR101905021B1 (ko) * | 2017-01-02 | 2018-10-05 | 주식회사 케미랜드 | 화장료용 색소 또는 기능성 성분을 함유하는 다중캡슐 및 이의 제조방법 |
CN114368827B (zh) * | 2021-11-29 | 2024-03-22 | 顺德职业技术学院 | 基于生物微胶囊技术的高效污水净化可降解填料 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4389419A (en) * | 1980-11-10 | 1983-06-21 | Damon Corporation | Vitamin encapsulation |
US4933185A (en) * | 1986-09-24 | 1990-06-12 | Massachusetts Institute Of Technology | System for controlled release of biologically active compounds |
EP1261420A1 (de) * | 2000-02-29 | 2002-12-04 | Rainer Pommersheim | Mikrokapsel insbesondere zur immobilisierung von organischen oder anorganischen feststoffen, flüssigkeiten und/oder gasen |
-
2005
- 2005-01-31 WO PCT/EP2005/000927 patent/WO2005072708A1/de active Application Filing
- 2005-01-31 JP JP2006550129A patent/JP2007534466A/ja active Pending
- 2005-01-31 EP EP05701273A patent/EP1718278A1/de not_active Withdrawn
- 2005-01-31 CA CA002553657A patent/CA2553657A1/en not_active Abandoned
- 2005-01-31 US US10/587,494 patent/US20070292687A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO2005072708A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005072708A1 (de) | 2005-08-11 |
US20070292687A1 (en) | 2007-12-20 |
JP2007534466A (ja) | 2007-11-29 |
CA2553657A1 (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68921266T2 (de) | Waschmittelzusammensetzungen. | |
EP1305109B1 (de) | Polyelektrolytkapselherstellung durch oberflächenpräzipitation | |
EP1064087B1 (de) | Herstellung von nano- und mikrokapseln durch schichtweise polyelektrolyt-selbstassemblierung | |
DE2642032C2 (de) | Verfahren zur Inkorporierung von Wirkstoffen in siliciumdioxidhaltige Trägermaterialien und eine siliciumdioxidhaltige Zubereitung | |
DE69702666T3 (de) | Verfahren zur herstellung von aktive stoffe enthaltenden mikrokapseln und mit einem polymer umgehüllten | |
DE10104841A1 (de) | Kapseln-in-Kapsel-System und Verfahren zu seiner Herstellung | |
DE69835275T2 (de) | Absorbens zum reinigen von körperflüssigkeiten | |
DE3209045C2 (de) | Verfahren zum selektiven Aufbrechen permeabler Membranen | |
DE3306259C2 (de) | Mikrokapseln und Verfahren zu ihrer Herstellung | |
DE69624363T2 (de) | Kontinuierliches herstellen von kapseln, die ein empfindliches material enthalten | |
CH653914A5 (de) | Verfahren zum einkapseln eines chemisch aktiven kernmaterials. | |
DE19812083A1 (de) | Herstellung von Nano- und Mikrokapseln durch schichtweise Polyelektrolyt-Selbstassemblierung | |
DE2016484C3 (de) | Verfahren zur Erhöhung der Wasserlöslichkeit von Mikrokapseln | |
EP1349913A1 (de) | Wasch- und reinigungsaktive substanzen enthaltende mikrokapseln | |
DE10205872A1 (de) | Mikrokapsel insbesondere zur Immobilisierung von organischen oder anorganischen Feststoffen, Flüssigkeiten und/oder Gasen | |
DE69602933T2 (de) | Verfahren zur mikroverkapselung | |
EP1718278A1 (de) | Mikrokapsel mit steuerbarer oder verzögerter freisetzung zur immobilisierung von chemischen und/oder biologischen materialien sowie verfahren zu ihrer herstellung | |
DE10306604A1 (de) | Kosmetische Zubereitungen mit Wirkstoffen in Mikrokapseln | |
EP0680753A2 (de) | Metalloxidkomposit mit steuerbarer Wirkstoffabgabe | |
WO2001064329A1 (de) | Mikrokapsel insbesondere zur immobilisierung von organischen oder anorganischen feststoffen, flüssigkeiten und/oder gasen | |
DE1943608A1 (de) | Enzym enthaltende Mikrokapseln und Verfahren zu deren Herstellung | |
DE19902724A1 (de) | Mikrokapseln aus Sporopollenin, Verfahren zu ihrer Herstellung und Anwendung | |
DE102004009051A1 (de) | Mikrokapsel mit verzögerter Freisetzung zur Immobilisierung von chemischen und/oder biologischen Materialien sowie Verfahren zu ihrer Herstellung | |
DE69807123T2 (de) | Herstellung von mikrokapseln mit mehreren wänden aus hydrophilen polymeren | |
DE102004005054A1 (de) | Mikrokapsel mit steuerbarer Freisetzung zur Immobilisierung von chemischen und/oder biologischen Materialien sowie Verfahren zu ihrer Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060704 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080801 |